Elisabeth De Leeuw

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.

Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.

Journal: Science immunology
Published: January 30, 2026

Maternal allergy and neonatal RSV infection synergize via FcR-mediated allergen uptake to promote the development of asthma in early life.

Maternal allergy and neonatal RSV infection synergize via FcR-mediated allergen uptake to promote the development of asthma in early life.

Journal: Science immunology
Published: November 28, 2025

Development of human innate immune responses in a humanized mouse model expressing four human myelopoiesis transgenes.

Development of human innate immune responses in a humanized mouse model expressing four human myelopoiesis transgenes.

Journal: Frontiers in immunology
Published: April 17, 2024

The role of dendritic cells in respiratory viral infection.

The role of dendritic cells in respiratory viral infection.

Journal: European respiratory review : an official journal of the European Respiratory Society
Published: December 05, 2023

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.

A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.

Journal: Science translational medicine
Published: August 23, 2023

Isolation of Conventional Murine Lung Dendritic Cell Subsets.

Isolation of Conventional Murine Lung Dendritic Cell Subsets.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 30, 2022

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.

Journal: Respiratory research
Published: April 29, 2022

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment.

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment.

Journal: Cell reports. Medicine
Published: April 14, 2022

Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent.

Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent.

Journal: Cytokine
Published: December 22, 2021

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.

Journal: The Journal of experimental medicine
Published: June 28, 2021

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.

Journal: The Lancet. Respiratory medicine
Published: June 25, 2021

Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.

Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.

Journal: Trials
Published: November 04, 2020
Showing 1-12 of 17

Last Updated: 09/26/2026